应激颗粒决定肥胖相关胰腺癌的发生发展
本研究建立应激颗粒(SG)与胰腺导管腺癌(PDAC)的因果关系,发现肥胖相关PDAC对SG依赖显著增强;SRPK2是肥胖相关PDAC中SG形成的特异性决定因子,由IGF1/PI3K/mTOR/S6K1通路过度激活驱动,抑制S6K1可选择性减弱SG并损害肥胖相关PDAC发展。
要点
- 应激颗粒与胰腺导管腺癌发生存在因果关系,肥胖相关PDAC对SG依赖显著增强。
- SRPK2是肥胖相关PDAC中SG形成的特异性决定因子。
- S6K1抑制可选择性减弱SG并损害肥胖相关PDAC发展。
核心结论
- 通过相分离细胞器SG的应激适应介导PDAC发展。
- 肥胖等既存应激条件是肿瘤SG依赖的驱动力,SG水平升高是肥胖相关PDAC的关键决定因素和化学预防靶点。
研究设计与样本
- 基础研究,建立SG与胰腺导管腺癌的因果关系并探讨肥胖相关PDAC中SG依赖及SRPK2作用。
主要发现
- 肥胖相关PDAC对SG的依赖显著增强。
- SRPK2是肥胖相关PDAC中SG形成的特异性决定因子,由IGF1/PI3K/mTOR/S6K1通路过度激活驱动。
- 抑制S6K1可选择性减弱SG并损害肥胖相关PDAC发展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Obesity is a global epidemic and a major predisposing factor for cancer. Increasing evidence shows that obesity-associated stress is a key driver of cancer risk and progression. Previous work has identified the phase-separation organelles, stress granules (SG), as mutant KRAS-dependent mediators of stress adaptation. However, the dependence of tumorigenesis on these organelles is unknown. Here, we establish a causal link between SGs and pancreatic ductal adenocarcinoma (PDAC). Importantly, we uncover that dependence on SGs is drastically heightened in obesity-associated PDAC. Furthermore, we identify a previously unknown regulator and component of SGs, namely, the serine/arginine protein kinase 2 (SRPK2), as a specific determinant of SG formation in obesity-associated PDAC. We show that SRPK2-mediated SG formation in obesity-associated PDAC is driven by hyperactivation of the IGF1/PI3K/mTOR/S6K1 pathway and that S6K1 inhibition selectively attenuates SGs and impairs obesity-associated PDAC development. SIGNIFICANCE: : We show that stress adaptation via the phase-separation organelles SGs mediates PDAC development. Moreover, preexisting stress conditions such as obesity are a driving force behind tumor SG dependence, and enhanced SG levels are key determinants and a chemopreventive target for obesity-associated PDAC. This article is highlighted in the In This Issue feature, p. 1825.
引用
- Fonteneau G, Redding A, Hoag-Lee H, et al. Stress Granules Determine the Development of Obesity-Associated Pancreatic Cancer. Cancer Discov. 2022. PMID: 35674408. doi:10.1158/2159-8290.CD-21-1672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。